AI assistant
Sending…
DEXCOM INC — Director's Dealing 2021
Jan 13, 2021
30198_dirs_2021-01-12_1305c26e-74b6-4776-a35b-0a9695560316.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-01-08
Reporting Person: SAYER KEVIN R (Director, Chairman, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-08 | Common Stock | A | 75910 | $0.0 | Acquired | 191424 | Direct |
Footnotes
F1: Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2018 that vested on January 8, 2021, with the applicable performance achieved.
F2: Included in this number are 56,792 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 17,915 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 13,424 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
More from DEXCOM INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Regulatory Filings
2026
May 28
Transaction in Own Shares
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Board/Management Information
2026
Mar 2
Director's Dealing
2026
Feb 26
Board/Management Information
2026
Feb 26
Director's Dealing
2026
Feb 17